156 related articles for article (PubMed ID: 1080551)
1. Quantal release parameters during fade of endplate potentials.
Branisteanu DD; Miyamoto MD; Volle RL
Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):323-7. PubMed ID: 1080551
[TBL] [Abstract][Full Text] [Related]
2. Pre- and postjunctional neuromuscular blockade by carbachol.
Volle RL; Henderson EG
Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(4):359-70. PubMed ID: 1082104
[TBL] [Abstract][Full Text] [Related]
3. Effects of physiologic alterations on binomial transmitter release at magnesium-depressed neuromuscular junctions.
Branisteanu DD; Miyamoto MD; Volle RL
J Physiol; 1976 Jan; 254(1):19-37. PubMed ID: 175150
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
[TBL] [Abstract][Full Text] [Related]
5. The effects of tetraphenylboron on neuromuscular transmission in the frog.
Marshall IG; Parsons RL
Br J Pharmacol; 1975 Jul; 54(3):325-32. PubMed ID: 169931
[TBL] [Abstract][Full Text] [Related]
6. [Postactivation shifts in the frequency of the miniature potentials of the endplate on stimulation of the motor nerve with rhythms close to the natural].
Kamenskaia MA; Demekhina KI
Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 0(8):36-41. PubMed ID: 4425708
[No Abstract] [Full Text] [Related]
7. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
Volle RL; Branisteanu DD
J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
[TBL] [Abstract][Full Text] [Related]
8. Activity increases quantal size at the frog neuromuscular junction.
Van der Kloot W; Van der Kloot TE
Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
[TBL] [Abstract][Full Text] [Related]
9. Frequency dependent decrease of quantal content in a drug-treated neuromuscular junction.
Volle RL
Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(3):271-84. PubMed ID: 4354638
[No Abstract] [Full Text] [Related]
10. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
Herrera AA
J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
[TBL] [Abstract][Full Text] [Related]
11. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
Barton SB; Cohen IS; van der Kloot W
J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
[TBL] [Abstract][Full Text] [Related]
12. Rates of transmitter turnover at the frog neuromuscular junction estimated by electrophysiological techniques.
Capek R; Esplin DW; Salehmoghaddam S
J Neurophysiol; 1971 Sep; 34(5):831-41. PubMed ID: 4328958
[No Abstract] [Full Text] [Related]
13. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
Miyamoto MD
J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
[TBL] [Abstract][Full Text] [Related]
14. The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.
Wiegand H; Lohmann H; Chandra SV
Arch Toxicol; 1986 Apr; 58(4):265-70. PubMed ID: 2424403
[TBL] [Abstract][Full Text] [Related]
15. [Binomial parameters of mediator release in the process of facilitation of neuromuscular transmission].
Zefirov AL
Neirofiziologiia; 1980; 12(3):314-6. PubMed ID: 6105625
[TBL] [Abstract][Full Text] [Related]
16. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
Kita H; van der Kloot W
J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
[TBL] [Abstract][Full Text] [Related]
17. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
Zengel JE; Magleby KL
J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
Molgó J; Lemeignan M; Lechat P
Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
[TBL] [Abstract][Full Text] [Related]
19. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
Augustine GJ; Levitan H
J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
[TBL] [Abstract][Full Text] [Related]
20. [Effect of etimizol on the neuromuscular synapse of the frog].
Drabkina TM; Dobretsov MG
Neirofiziologiia; 1985; 17(6):757-63. PubMed ID: 3003594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
